kyvernatx.com (KYTX) - Bozor qiymatining balans qiymatiga nisbati
GURU.Markets platformasida Kyverna Therapeutics (KYTX) aksiyalarining vizuallashtirilgan narx harakati CAR-T ishlanmalarini kengaytirish orqali global ekspansiya yo'nalishiga asoslangan bo'lib, joriy ko'rsatkich 2.14 darajasida turibdi. Kyverna Therapeutics og'ir patologiyalarda immunitetni tiklash uchun onkologik usullarni qayta ko'rib chiqmoqda. Bundan tashqari, kompaniya skleroz va tizimli qizil bo'tanka (systemic lupus erythematosus) uchun aniq terapiya usullarini yaratishni maqsad qilgan.
Kyverna Therapeutics Inc. (KYTX) - koʻrsatkichlar kesimi va moliyaviy hisobotlar
- aksiya narxi va baholash bo'yicha konsensus prognoz:
- bozor kapitallashuvi ko'rsatkichlari:
- balans kapitallashuvi bo'yicha ma'lumotlar:
- qarz majburiyatlari va likvidlik statistikasi:
Qarzning xususiy kapitalga nisbati Kyverna Therapeutics|KYTX - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Qisqa muddatli qarzning o'z kapitaliga nisbati Kyverna|KYTX - Kompaniyaning umumiy qarzi|Balans kapitallashuviga qarzlar Kyverna|KYTX - Kompaniyaning uzoq muddatli qarzlari|Kompaniyaning qisqa muddatli majburiyatlari Kyverna Therapeutics|Tezkor likvidlik koeffitsiyenti kyvernatx.com
- foyda va baholash multiplikatorlari ko'rsatkichlari:
Kompaniyaning asosiy tahlili:Kyverna Therapeutics - KYTX
Kyverna Therapeutics kompaniyasining autoimmun kasalliklar uchun hujayra terapiyasi sohasidagi innovator sifatidagi maqomi joriy bozor kapitalizatsiyasining buxgalteriya qiymatiga nisbatini belgilaydi. Ushbu koeffitsient biznesning bozor qiymatini uning sof aktivlari bilan solishtirib, investorlarning kompaniyaning ilmiy nufuzini kapitalga aylantirish va ortib borayotgan operatsion xarajatlarga samarali qarshi turish qobiliyatiga bo'lgan ishonch darajasini ko'rsatadi.
Raqobatchilar tahlili
ARGX (argenx SE) - Kapitallashuvning sof aktivlarga nisbati|Kapitallashuvning balans qiymatiga nisbati BNTX|Bozor qiymatining balans qiymatiga nisbati abivax.com|ADMA Biologics Inc - Sof aktivlarga nisbatan bozor kapitallashuvi|Bozor kapitallashuvining balans qiymatiga nisbati PTGX|IMVT (Immunovant Therapeutics) - Balans qiymatiga nisbatan bozor qiymati|Bozor kapitallashuvining balans qiymatiga nisbati KNSA (Kiniksa Pharmaceuticals)|Bozor kapitallashuvining balans qiymatiga nisbati grifols.com GRFS|ADPT - Bozor qiymatining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor qiymati CLDX (Celldex Therapeutics Inc)|Aurinia Pharma (AUPH) - Bozor qiymatining balans qiymatiga nisbati|Kapitallashuvning sof aktivlarga nisbati BioCryst Corp|VERA (Vera Therapeutics, Inc.) - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati dianthustx.com|Kapitallashuvning sof aktivlarga nisbati PHVS (Pharvaris)|ABCL (AbCellera Biologics) - Balans qiymatiga nisbatan bozor qiymati|Bozor kapitallashuvining balans qiymatiga nisbati TRML (Tourmaline Corp)|Balans qiymatiga nisbatan bozor kapitallashuvi Precigen Corp (PGEN)|PHAR - Bozor qiymatining balans qiymatiga nisbati|nektar.com (NKTR) - Kapitallashuvning sof aktivlarga nisbati|Upstream Bio (UPB) - Bozor qiymatining balans qiymatiga nisbati|Kapitallashuvning sof aktivlarga nisbati Zenas Bio|Kapitallashuvning sof aktivlarga nisbati IMNM|Bozor kapitallashuvining balans qiymatiga nisbati Gossamer Bio Corp.|Bozor qiymatining balans qiymatiga nisbati KalVista Pharmaceuticals (KALV)|septerna.com - Kapitallashuvning balans qiymatiga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati PVLA (Pieris Pharmaceuticals, Inc.)|Savara Inc (SVRA) - Bozor qiymatining balans qiymatiga koeffitsiyenti|RIGL - Bozor qiymatining balans qiymatiga nisbati|ANAB - Bozor kapitallashuvining balans qiymatiga nisbati|ATXS (Astria Therapeutics) - Kapitallashuvning sof aktivlarga nisbati|Bozor qiymatining balans qiymatiga koeffitsiyenti engene.com (ENGN)|Kapitallashuvning sof aktivlarga nisbati RAPT|Bozor qiymatining balans qiymatiga nisbati JBIO|Bozor kapitallashuvining balans qiymatiga nisbati ACRS|TLSA - Bozor qiymatining balans qiymatiga koeffitsiyenti|Bozor qiymatining balans qiymatiga nisbati Cabaletta Bio, Inc. CABA|Balans qiymatiga nisbatan bozor qiymati VTYX|THTX - Bozor qiymatining balans qiymatiga nisbati|AVTX (Avalo Therapeutics, Inc.) - Kapitallashuvning balans qiymatiga nisbati|ELDN: Bozor kapitallashuvining balans qiymatiga nisbati|Agenus, Inc (AGEN) - Bozor kapitallashuvining balans qiymatiga nisbati|Kapitallashuvning sof aktivlarga nisbati CLYM|ZURA: Balans qiymatiga nisbatan bozor qiymati|Kapitallashuvning sof aktivlarga nisbati ATYR (aTyr Pharma)|Bozor kapitallashuvining balans qiymatiga multiplikatori ADAG|Bozor kapitallashuvining balans qiymatiga nisbati IMA (Ikena Oncology)|Balans qiymatiga nisbatan bozor qiymati STTK|Equillium Bio - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga koeffitsiyenti Connect Biopharma|immunic-therapeutics.com (IMUX) - Bozor qiymatining balans qiymatiga nisbati|Atara Bio - Balans qiymatiga nisbatan bozor qiymati|IFRX (InflaRx NV) - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati X4 Pharmaceuticals, Inc|Bozor qiymatining balans qiymatiga nisbati Adicet Bio (ACET)|CELU: Sof aktivlarga nisbatan bozor kapitallashuvi|Bozor kapitallashuvining balans qiymatiga nisbati INMB (INmune Bio)|Barinthus Biotherapeutics PLC (BRNS) - Bozor qiymatining balans qiymatiga koeffitsiyenti|KZR: Kapitallashuvning sof aktivlarga nisbati|SABS - Bozor kapitallashuvining balans qiymatiga nisbati|AKTX (Akari Therapeutics) - Kapitallashuvning sof aktivlarga nisbati|ENLV: Bozor kapitallashuvining balans qiymatiga multiplikatori|QTTB (Q32 Bio Inc) - Bozor kapitallashuvining balans qiymatiga nisbati|GeoVax Labs (GOVX) - Balans qiymatiga nisbatan bozor kapitallashuvi|Bozor kapitallashuvining balans qiymatiga nisbati EDSA|Kapitallashuvning sof aktivlarga nisbati iBio Corporation IBIO|Bozor qiymatining balans qiymatiga nisbati Carisma Therapeutics Inc. CARM|Balans qiymatiga nisbatan bozor kapitallashuvi xtlbio.com (XTLB)|BOLT - Bozor qiymatining balans qiymatiga nisbati|HCWB - Bozor kapitallashuvining balans qiymatiga nisbati|APVO (aptevotherapeutics.com) - Kapitallashuvning sof aktivlarga nisbati|Bozor qiymatining balans qiymatiga koeffitsiyenti aimimmuno.com (AIM)|Kapitallashuvning sof aktivlarga nisbati ADTX|GRI (gribio.com) - Bozor kapitallashuvining balans qiymatiga multiplikatori|Kapitallashuvning sof aktivlarga nisbati XRTX (XORTX Therapeutics)|Vyome Holdings Inc. - Kapitallashuvning balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga nisbati Revelation Bio REVB|INDP (Indaptus Corp) - Sof aktivlarga nisbatan bozor kapitallashuvi|Scinai Immunotherapeutics - Bozor kapitallashuvining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor qiymati CALI (CalciMedica, Inc.)|AFMD: Bozor kapitallashuvining balans qiymatiga nisbati|Allakos (ALLK) - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga nisbati HOOKIPA Pharma, Inc.|IGMS: Balans qiymatiga nisbatan bozor qiymati|Bozor qiymatining balans qiymatiga nisbati iTeos Therapeutics (ITOS)|Kapitallashuvning sof aktivlarga nisbati oceanbiomedical.com OCEA|Bozor kapitallashuvining balans qiymatiga nisbati TCBP (TC BioPharm)|Bozor kapitallashuvining balans qiymatiga nisbati Third Harmonic Bio Inc. THRD